As of June 30, 2026, Groove Botanicals, Inc. carries a market capitalization of 238,572.25, placing it among publicly traded companies globally. Its enterprise value stands at 237,286.25, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 238,572.25 |
| Enterprise Value | 237,286.25 |
As of June 30, 2026, Groove Botanicals, Inc. has 59.64M shares outstanding.
| Shares Outstanding | 59.64M |
These figures are as of June 30, 2026.
| PB Ratio | -0.15 |
| P/TBV Ratio | -0.15 |
| P/FCF Ratio | -2.77 |
| P/OCF Ratio | -2.77 |
These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -3,958.07, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 2.00, a quick read on workforce productivity versus industry peers.
| Return on Assets (ROA) | -3,958.07 |
| Employee Count | 2.00 |
As of the close on October 13, 2026, Groove Botanicals, Inc.'s stock has declined approximately 36.71% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.05.
| 52-Week Price Change | -36.71% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.05 |
Over the twelve months ended June 30, 2026, Groove Botanicals, Inc. generated - - in revenue and converted that into -122,918.00 in net income, yielding earnings per share of 0.00. EBITDA reached -130,065.00, while operating income came in at -130,065.00.
| Operating Income | -130,065.00 |
| Pretax Income | -122,918.00 |
| Net Income | -122,918.00 |
| EBITDA | -130,065.00 |
| EBIT | -130,065.00 |
These figures are as of June 30, 2026. Total book value stands at -1.54M, with working capital of -1.54M providing operational flexibility.
| Cash & Cash Equivalents | 1,494.00 |
| Net Debt | -1,494.00 |
| Equity (Book Value) | -1.54M |
| Book Value Per Share | -0.03 |
| Working Capital | -1.54M |
Groove Botanicals, Inc. produced -86,069.00 in operating cash flow over the twelve months ended June 30, 2026.
| Operating Cash Flow | -86,069.00 |
| Free Cash Flow | -86,069.00 |
These figures cover the twelve months ended June 30, 2026. The dividend payout ratio of 63.99 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -36.08: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -35.56, meaning Groove Botanicals, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Payout Ratio | 63.99 |
| Shareholder Yield | -35.56 |
| FCF Yield | -36.08 |
Groove Botanicals, Inc.'s most recent stock split took place on July 24, 2012 with a 300:1 split ratio.
| Last Split Date | 7/24/2012 |
| Split Ratio | 300:1 |
As of June 30, 2026, Groove Botanicals, Inc. has an Altman Z-Score of -20,659.36, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -20,659.36 |